Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine Neoplasms

Endocrine Research · Published 2024-07-23 · DOI 10.1080/07435800.2024.2365895

Authors being retrieved — see the publisher record. https://doi.org/10.1080/07435800.2024.2365895

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Broad-Spectrum Effects of Carbohydrate Reduction on Inflammatory and Immune Mediators in Type 2 Diabetes · Endocrine Research · 2026 · Same journal
• Effects of Moderate-Intensity Aerobic Exercise on Estrogen Levels and Bone Mineral Density in Ovariectomized Rats · Endocrine Research · 2025 · Same journal
• Epigenetic analysis reveals aberrant aging in thyroid cancer · Endocrine Research · 2026 · Same journal
• Menopause and diabetes: Interconnected associations of risk · Endocrine Research · 2025 · Same journal
• Chemical chaperone TUDCA rescues Insulin-mediated vascular relaxation via ER stress inhibition in diabetic rat model · Endocrine Research · 2026 · Same journal
• Interaction between interleukin 10 ( IL-10 ) gene polymorphisms and obesity on susceptibility to polycystic ovary syndrome in Chinese women · Endocrine Research · 2025 · Same journal
• Investigation of serum orexin-A levels in women with polycystic ovary syndrome · Endocrine Research · 2026 · Same journal
• Evaluation of the Effectiveness of In-Hospital Exercise Rehabilitation in Middle-Aged and Elderly Patients with Type 2 Diabetes Mellitus Combined with Sarcopenia Effect of Lifestyle Management on Disease Status in Patients with Type 2 Diabetes Mellitus · Endocrine Research · 2024 · Same journal
• Possible sarcopenia and risk of chronic kidney disease: a four-year follow-up study and Mendelian randomization analysis · Endocrine Research · 2024 · Same journal
• Treatment Outcomes in Patients with Recurrent Adrenocortical Carcinoma · Endocrine Research · 2024 · Same journal